On July 8, a research team from the University of California, San Diego, published a groundbreaking study in Nature, showcasing the G1 humanoid robot, nicknamed 'Surgie.' This robot, weighing 27 kg and priced from $13,500, successfully performed two laparoscopic cholecystectomies on live pigs, marking a significant milestone in robotic surgery.
The significance of this achievement lies in the G1's affordability and adaptability compared to traditional surgical robots like the da Vinci system, which costs between $500,000 and several million dollars. Surgeon's remote control of the G1 allows for deployment in various settings, including rural areas, battlefields, and potentially space missions, without the need for specialized operating room modifications.
Despite the success, the technology still faces challenges before clinical application, such as the need for frequent recalibration during surgery, which increases operation time. The G1's limited arm span of 450 mm also restricts its operational range. No further timeline was disclosed at the time of publication for the next steps in this research.
Editor's Note
The introduction of affordable humanoid robots like the G1 could disrupt the surgical robotics market, making advanced surgical procedures more accessible across diverse environments.
Leave a comment